Research Article

Functional Inflammatory Genotypes in Ischemic Stroke: Could We Use Them to Predict Age of Onset and Long-Term Outcome?

Table 4

Association of inflammatory genotypes with long-term functional outcome of an IS.

GenotypesLogistic regression
TNF-α-308G>APresence of GG
6-month outcomeAGGGOR*95% CI 𝑃

(BI: 16–20) good (%)
(BI: <16, or death) bad (%)
15 (17)
13 (25.5)
73 (83)
38 (74.5)
Referent
0.19
0.04–0.86.03

IL6-174G>CPresence of GC/CC
GGGC/CCOR*95% CI 𝑃

(BI: 16–20) good (%)
(BI: <16, or death) bad (%)
54 (64.3)
34 (62.8)
30 (35.7)
21 (38.2)
Referent
1.14
0.37–3.54.82

IL12B 1188A>CPresence of AC
AA/CCACOR*95% CI 𝑃

(BI: 16–20) good (%)
(BI: <16, or death) bad (%)
48 (54.5)
37 (72.5)
40 (45.5)
14 (27.5)
Referent
0.69
0.23–2.09.52

IL4-589C>TPresence of CT
CCCTOR*95% CI 𝑃

(BI: 16–20) good (%)
(BI: <16, or death) bad (%)
71 (84.1)
43 (84.3)
14 (15.9)
8 (15.7)
Referent
0.67
0.17–2.59.56

IL10-1082G>APresence of GG
GGAG/AAOR*95% CI 𝑃

(BI: 16–20) good (%)
(BI: <16, or death) bad (%)
14 (15.9)
12 (23.5)
74 (84.1)
39 (76.5)
Referent
2.65
0.57–12.40.22

BI: barthel index, OR: odds ratio, CI: confidence intervals.
*ORs adjusted for age, sex, hypertension, diabetes, hyperlipidemia, ischemic heart disease, smoking, stroke severity on admission and TOAST categories.